These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38326066)

  • 1. [OCT analysis of in-stent neointima over 5 years post-DES implantation].
    Han Y; Yuan XH; Jiang MT; Feng HH; Zhang X; Zhang YQ; Jing J; Chen YD; Gao L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Feb; 52(2):150-157. PubMed ID: 38326066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.
    Lee SJ; Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Clin Cardiol; 2011 Oct; 34(10):633-9. PubMed ID: 21928365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
    Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
    Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the monocytes to high-density lipoprotein cholesterol ratio with in-stent neoatherosclerosis and plaque vulnerability: An optical coherence tomography study.
    Rong J; Gu N; Tian H; Shen Y; Deng C; Chen P; Ma S; Ma Y; Hu X; Zhao R; Shi B
    Int J Cardiol; 2024 Feb; 396():131417. PubMed ID: 37802300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
    Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
    Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between pre-procedural plaque morphology and patterns of in-stent neointimal hyperplasia at 1-year follow-up in patients treated with new-generation drug-eluting stents: An optical coherence tomography based analysis.
    Shi SY; Chen KL; Gu J; Xu C; Chen QR; Chen YQ; Xu T; Ke HY; Sun JH; Ye F
    J Interv Cardiol; 2018 Dec; 31(6):737-746. PubMed ID: 30251273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study.
    Yuan X; Jiang M; Feng H; Han Y; Zhang X; Chen Y; Gao L
    Heliyon; 2023 Aug; 9(8):e19073. PubMed ID: 37636400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Neoatherosclerosis Patterns in Drug-Eluting- and Bare-Metal Stent Restenosis　- Optical Coherence Tomography Study.
    Nakamura D; Yasumura K; Nakamura H; Matsuhiro Y; Yasumoto K; Tanaka A; Matsunaga-Lee Y; Yano M; Yamato M; Egami Y; Shutta R; Sakata Y; Tanouchi J; Nishino M
    Circ J; 2019 Jan; 83(2):313-319. PubMed ID: 30487370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of recurrent in-stent restenosis after second- and third-generation drug-eluting stent implantation.
    Shimono H; Kajiya T; Takaoka J; Miyamura A; Inoue T; Kitazono K; Ninomiya T; Atsuchi Y; Atsuchi N; Ohishi M
    Coron Artery Dis; 2021 Jan; 32(1):36-41. PubMed ID: 32826448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very late stent thrombosis related to incomplete neointimal coverage or neoatherosclerotic plaque rupture identified by optical coherence tomography imaging.
    Amabile N; Souteyrand G; Ghostine S; Combaret N; Slama MS; Barber-Chamoux N; Motreff P; Caussin C
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):24-31. PubMed ID: 23720378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis.
    Jang JY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Atherosclerosis; 2015 Oct; 242(2):553-9. PubMed ID: 26318104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation　- An Optical Coherence Tomography Study.
    Jinnouchi H; Kuramitsu S; Shinozaki T; Tomoi Y; Hiromasa T; Kobayashi Y; Domei T; Soga Y; Hyodo M; Shirai S; Ando K
    Circ J; 2017 Mar; 81(4):450-457. PubMed ID: 28132981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally Occurring Atherosclerosis Progression and In-stent Restenosis: Exploring Histomorphologic Associations Using Optical Coherence Tomography.
    Zhang W; Zhang W; Gu N; Qiu Z; Pan L; Zhao Y; Shi B
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):646-654. PubMed ID: 38030142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    EuroIntervention; 2017 Jun; 13(3):294-302. PubMed ID: 28320686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.